Erika Ayers Badan: What Do You Want?
Please meet Cynthia Pong. She came to me by way of super-connector and personal board director an occasional SVU actor, Sarah Storm. Cynthia Pong packs…
Thought Leader: Erika Ayers Badan
By Scott Gottlieb (original source Health Affairs)
“In recent years, considerable bipartisan Congressional action, leadership from both Democratic and Republican administrations, and broad-based multistakeholder collaborations have focused on improving the tools and regulatory processes at the Food and Drug Administration (FDA), other government agencies, and public-private collaborations to support more efficient and timely development of new medical technologies. Enhanced funding through user fees and the bipartisan Twenty-First Century Cures legislation have supported a robust and better-resourced FDA and enabled science-driven collaborations in a range of areas including innovative clinical trials, “patient-focused” drug development, and greater clarity around standards for regulatory approval of new technologies.”
Click here to read more
Erika Ayers Badan: What Do You Want?
Please meet Cynthia Pong. She came to me by way of super-connector and personal board director an occasional SVU actor, Sarah Storm. Cynthia Pong packs…
Thought Leader: Erika Ayers Badan
Patrick McGee: Foreign Affairs Best Books of 2025
McGee, a Financial Times journalist, brings his investigative skills to bear on the fascinating history of how, over a quarter century, China and the technology…
Thought Leader: Patrick McGee
Dr. Sanjay Gupta: How to Identify Medical Misinformation
As a practicing neurosurgeon and CNN’s chief medical correspondent, Dr. Sanjay Gupta can spot false health claims from a mile away. Still, he recently became…
Thought Leader: Sanjay Gupta